Stevanato Group Spa (STVN) has released an update.
Stevanato Group Spa, a prominent player in providing pharmaceutical solutions, has announced an upsized public offering of 12.7 million ordinary shares at $26 each, expecting to raise approximately $330 million before fees. The company plans to use the proceeds for general corporate purposes and to maintain operational and strategic flexibility, with the offering projected to close on March 26, 2024. The offering’s lead book-running managers include Morgan Stanley and William Blair, among other notable financial institutions.
For further insights into STVN stock, check out TipRanks’ Stock Analysis page.
